Pages that link to "Q42476892"

The following pages link to Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus (Q42476892):

Displaying 20 items.

• Kynurenine 3-monooxygenase (Q28557333) (← links)
• Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory (Q30504501) (← links)
• Vasorelaxing Action of the Kynurenine Metabolite, Xanthurenic Acid: The Missing Link in Endotoxin-Induced Hypotension? (Q33619271) (← links)
• Kynurenine Pathway Metabolites in Humans: Disease and Healthy States (Q34633683) (← links)
• Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias (Q34809151) (← links)
• Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration (Q35054916) (← links)
• Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats (Q35985369) (← links)
• The tryptophan oxidation pathway in mosquitoes with emphasis on xanthurenic acid biosynthesis (Q36637156) (← links)
• Chemical gradients within brain extracellular space measured using low flow push-pull perfusion sampling in vivo (Q36638610) (← links)
• Pharmacological therapy in Parkinson's disease: focus on neuroprotection (Q37741285) (← links)
• Major developments in the design of inhibitors along the kynurenine pathway (Q38808400) (← links)
• Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? (Q42500404) (← links)
• Established therapies and novel targets in the treatment of Parkinson's disease (Q42723595) (← links)
• Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain (Q46933509) (← links)
• LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning (Q47387394) (← links)
• Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse (Q47403660) (← links)
• Reply to: kynurenic acid and alcohol and cocaine dependence: novel effects and multiple mechanisms? (Q47865980) (← links)
• Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model (Q60691189) (← links)
• Kynurenine-3-monooxygenase: A new direction for the treatment in different diseases (Q90149959) (← links)
• Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease (Q92381661) (← links)